Subgen AI Feed

	Est. tid*
2026-11-05	09:00	Kvartalsrapport 2026-Q3
2026-08-20	09:00	Kvartalsrapport 2026-Q2
2026-05-21	N/A	Årsstämma
2026-05-07	09:00	Kvartalsrapport 2026-Q1
2026-03-31	08:00	Bokslutskommuniké 2025
2025-12-17	N/A	Extra Bolagsstämma 2026
2025-11-25	-	Split SUBGEN 1000:1
2025-11-05	-	Extra Bolagsstämma 2025
2025-08-29	-	Kvartalsrapport 2025-Q2
2025-07-01	-	X-dag ordinarie utdelning SUBGEN 0.00 SEK
2025-06-30	-	Årsstämma
2025-03-05	-	Bokslutskommuniké 2024
2024-11-15	-	Kvartalsrapport 2024-Q3
2024-08-23	-	Kvartalsrapport 2024-Q2
2024-07-01	-	X-dag ordinarie utdelning SUBGEN 0.00 SEK
2024-06-28	-	Årsstämma
2024-04-26	-	Extra Bolagsstämma 2024
2024-03-29	-	Bokslutskommuniké 2023
2023-11-24	-	Kvartalsrapport 2023-Q3
2023-08-25	-	Kvartalsrapport 2023-Q2
2023-06-22	-	Årsstämma
2023-06-01	-	Kvartalsrapport 2023-Q1
2023-05-16	-	X-dag ordinarie utdelning SUBGEN 0.00 SEK
2023-03-31	-	Bokslutskommuniké 2022
2023-01-20	-	Extra Bolagsstämma 2022
2022-11-23	-	Kvartalsrapport 2022-Q3
2022-08-25	-	Kvartalsrapport 2022-Q2
2022-06-21	-	X-dag ordinarie utdelning SUBGEN 0.00 SEK
2022-06-20	-	Årsstämma
2022-05-25	-	Kvartalsrapport 2022-Q1
2022-02-25	-	Bokslutskommuniké 2021
2021-11-23	-	Kvartalsrapport 2021-Q3
2021-08-24	-	Kvartalsrapport 2021-Q2
2021-06-29	-	X-dag ordinarie utdelning SUBGEN 0.00 SEK
2021-06-28	-	Årsstämma
2021-05-25	-	Kvartalsrapport 2021-Q1
2021-03-09	-	Extra Bolagsstämma 2021
2021-02-26	-	Bokslutskommuniké 2020
2020-11-27	-	Kvartalsrapport 2020-Q3
2020-08-27	-	Kvartalsrapport 2020-Q2

Land	Sverige
Lista	First North Stockholm
Sektor	Hälsovård
Industri	Bioteknik

2025-12-05 08:00:00 Subgen AI Announces Partnership with Mindshore to Accelerate AI platform Serenity Star Adoption 4,89 SEK | +8,18% | 0,72 MSEK

2025-11-28 13:50:00 Notice of extraordinary general meeting in Subgen AI AB 9,08 SEK | -5,91% | 0,94 MSEK

2025-11-28 13:50:00 Kallelse till extra bolagsstämma i Subgen AI AB 9,08 SEK | -5,91% | 0,94 MSEK

2025-11-28 08:30:00 Subgen AI to present at Redeye Technology Day 2025 9,08 SEK | -5,91% | 0,94 MSEK

2025-11-28 08:00:00 Subgen AI AB: Certain sellers of Subgen AI Limited, including newly appointed members of the board and management, have entered into lock-up agreements 9,08 SEK | -5,91% | 0,94 MSEK

2025-11-27 08:00:00 Subgen AI announces strategic integration partnership with DISID to accelerate enterprise adoption 9,65 SEK | +6,06% | 0,62 MSEK

2025-11-21 08:45:00 Subgen AI AB: First day of trading under new ticker SUBGEN on Nasdaq First North Growth Market 14,50 SEK | +17,89%

2025-11-20 15:40:00 Record date for reverse share split in Subgen AI AB and recalculation of warrants of series TO 5 and TO 6 12,30 SEK | +46,43% | 1,65 MSEK

2025-11-20 11:05:00 Subgen AI AB updates its website and announces that the first day of trading under the new ticker will take place on 21 November 2025 12,30 SEK | +46,43% | 1,65 MSEK

2025-11-06 22:46:00 Magnasense completes the reverse takeover of Subgen AI 14,00 SEK | +16,67% | 6,22 MSEK

2025-11-06 17:54:00 Magnasense completes the sale of its subsidiaries 14,00 SEK | +16,67% | 6,22 MSEK

2025-11-05 12:08:00 Bulletin from the extraordinary general meeting in Magnasense AB on 5 November 2025 10,60 SEK | +15,22% | 12,1 MSEK

2025-10-29 08:55:00 Magnasense receives conditional approval for continued listing on Nasdaq First North Growth Market and publishes company description in connection with the reverse takeover of Subgen AI 6,20 SEK | +10,71% | 0,60 MSEK

2025-10-21 21:05:00 Subgen AI Foundation receives exemption from the Swedish Securities Council regarding mandatory bid in connection with Magnasense’s conditional reverse takeover of Subgen AI Limited 5,50 SEK | -3,51% | 0,06 MSEK

2025-10-03 12:26:00 Notice of extraordinary general meeting in Magnasense AB (publ) 5,50 SEK | -9,84% | 0,23 MSEK

2025-10-03 12:25:00 Kallelse till extra bolagsstämma i Magnasense AB (publ) 5,50 SEK | -9,84% | 0,23 MSEK

2025-09-29 22:36:00 Magnasense enters into a conditional settlement agreement with Atlas Special Opportunities, terminating all prior agreements and settling all existing claims through an intended directed issue 6,50 SEK | -13,33% | 0,89 MSEK

2025-09-20 15:06:00 Magnasense progresses planned reverse takeover by entering into a conditional share purchase agreement regarding the sale of its subsidiaries - Marco Witteveen to step down as CEO

2025-08-29 08:55:00 Magnasense Interim Report January - June 2025 5,80 SEK | -4,92% | 1,59 MSEK

2025-07-22 23:46:00 Magnasense enters into a conditional agreement regarding a reverse takeover of Subgen AI Limited 5,30 SEK | -13,11% | 5,60 MSEK

2025-07-16 21:14:00 Magnasense AB carries out directed issue of 784,095,000 shares to Atlas Special Opportunities, LLC following called upon conversions of approximately SEK 1.57 million 7,00 SEK | -30,00% | 16,7 MSEK

2025-07-14 22:36:00 The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended 5,80 SEK | +132,00% | 3,08 MSEK

2025-07-14 18:22:00 Magnasense AB files appeal against decision by Swedish Financial Supervisory Authority 5,80 SEK | +132,00% | 3,08 MSEK

2025-07-07 11:54:00 Vasiliki Fragkou Resigns from her position as Chief Operating Officer of Magnasense AB and as a director of AegirBio UK Ltd. 2,50 SEK | 0,00% | 0,36 MSEK

2025-06-30 11:37:00 REGULATORY PRESS RELEASE 3,00 SEK | +20,00% | 0,33 MSEK

2025-06-29 19:38:00 The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended 3,00 SEK | +20,00% | 0,33 MSEK

2025-06-25 09:02:00 Magnasense AB receives decision on penalty fee from the Swedish Financial Supervisory Authority 2,80 SEK | -42,86% | 1,08 MSEK

2025-06-20 18:43:00 Magnasense AB carries out previously announced directed issue of 416,666,666 shares to Atlas Special Opportunities, LLC following called upon conversions of SEK 2.50 million

2025-06-19 16:00:00 Magnasense intends to carry out a directed issue of shares to Atlas Special Opportunities, LLC due to called on conversions totalling SEK 2.50 million 6,00 SEK | -1,64% | 0,22 MSEK

2025-06-14 09:00:00 Magnasense AB carries out previously announced directed issue of 223,484,847 shares to Atlas Special Opportunities, LLC following called upon conversions of SEK 2.50 million

2025-06-11 21:00:00 Magnasense intends to carry out a directed issue to Atlas Special Opportunities, LLC due to called on conversions totalling SEK 2.50 million 9,70 SEK | -17,80% | 1,35 MSEK

2025-06-10 08:00:00 Magnasense enters into Letter of Intent with Subgen AI Limited regarding a reverse takeover 11,70 SEK | +1,74% | 4,53 MSEK

2025-06-09 16:06:00 Magnasense AB publishes annual report and audit report for the financial year 2024 11,50 SEK | -14,18% | 0,57 MSEK

2025-05-28 08:58:00 Magnasense resolves on directed issue of units to guarantor in connection with completed rights issue 51,10 SEK | -18,24% | 0,17 MSEK

2025-05-28 08:58:00 Magnasense beslutar om riktad emission av units till garant i samband med genomförd företrädesemission 51,10 SEK | -18,24% | 0,17 MSEK

2025-05-27 09:00:00 Notice of Annual General Meeting in Magnasense AB (publ) 62,50 SEK | -6,02% | 0,10 MSEK

2025-05-27 09:00:00 Kallelse till årsstämma i Magnasense AB (publ) 62,50 SEK | -6,02% | 0,10 MSEK

2025-05-26 12:47:00 Magnasense’s rights issue has been registered – conversion of paid subscribed units (BTU) and first day of trading in warrants of series TO 5 and TO 6 66,50 SEK | -4,86% | 0,08 MSEK

2025-05-26 12:47:00 Magnasenses företrädesemission har registrerats – omvandling av betalda tecknade units (BTU) samt första dag för handel med teckningsoptioner av serie TO 5 och TO 6 66,50 SEK | -4,86% | 0,08 MSEK

2025-05-12 23:00:00 Magnasense offentliggör utfall i företrädesemission av units 83,00 SEK | -4,05% | 0,04 MSEK

2025-05-12 23:00:00 Magnasense announces outcome in rights issue of units 83,00 SEK | -4,05% | 0,04 MSEK

2025-05-06 08:30:00 Magnasense Advances Saliva-Based Diagnostics Breakthrough with Partially Secured, Ongoing Rights Issue – Investors Welcome to Participate Until 8 May 2025 83,90 SEK | -2,21% | 0,11 MSEK

2025-05-05 11:43:00 Interview with Magnasense: Key Insights from the RADx Initiative 85,80 SEK | -9,68% | 0,20 MSEK

2025-05-01 10:32:00 Magnasense and Salignostics Successfully Complete Feasibility Study

2025-04-29 23:44:00 Magnasense receives additional guarantee commitments totalling approx. MSEK 8.8 in ongoing rights issue of units - the minimum level required for the completion of the issue is secured 86,80 SEK | +17,46% | 0,12 MSEK

2025-04-29 23:44:00 Magnasense erhåller ytterligare garantiåtaganden om totalt cirka 8,8 MSEK i pågående företrädesemission av units – lägstanivån som krävs för emissionens genomförande är säkerställd 86,80 SEK | +17,46% | 0,12 MSEK

2025-04-28 09:47:00 Magnasense AB Targets Gum Disease Market with Groundbreaking Diagnostic Technology — Capital Raise Underway to Accelerate Entry in High-Value Underserved Market 89,70 SEK | +9,39% | 0,20 MSEK

2025-04-25 10:00:00 Aegirbio UK Ltd and Undisclosed Partner Sign LOI to Develop Innovative Digital Diagnostic Product 82,00 SEK | -12,11% | 0,37 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Subgen AI

Prenumeration

Kalender

Beskrivning

Intresserad av bolagets nyckeltal?

Vem äger bolaget?

Subgen AI

Prenumeration

Kalender

Beskrivning

Intresserad av bolagets nyckeltal?

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden